1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Monthly Industry Forecasts > Chemicals

Monthly Industry Forecasts > Chemicals

  • October 2013
  • -
  • Oxford Economics

Although basic chemicals production in the UK rose by 4% on the month in August, output in the final quarter of the year is likely to drop back as a result of the temporary shutdown of the Grangemouth petrochemicals plant in the second half of October. The total period of time from when the shutdown of the petrochemicals site began to when it will become fully operational is estimated to be around 4 weeks. Elsewhere, German chemical production shrank, but a closer look shows that this was largely due to a sharp 5% drop in basic chemicals output. Meanwhile, French chemical production fell further whilst output in Italy rebounded after a marked fall in July.

Table Of Contents

Monthly Industry Forecasts > Chemicals
The following represents a general Table of Contents outline for the Monthly Industry Briefing on Chemicals. The actual report may cover any or all of the topics listed below.
Chemicals Monthly Industry Briefing
- Synopsis: Review and analysis of key data releases over the month, including trends.
- Historic Charts:
- Five years of historical data comparing output of BRICS, developed countries, Eastern Europe, US, EU15, UK, Italy, Japan, France, Germany and the World.
- Five years of historical data for output and new growth in the chemicals industry.
- Five years of historical data for output and new growth in the pharmaceuticals industry.
- Five years of historical data for output and new growth in the non-pharmaceuticals industry.
- Five years of historical data for new orders in chemicals, pharmaceutical and non-pharmaceuticals industries.
- Five years of historical data for inventories and capacity utilisation in the chemicals industry.
- Five years of historical data for chemical sales.
- Five years of historical data on pricing for chemicals.
- Forecast Charts: Four years of forecast data for output and growth for BRICS, developed countries, Eastern Europe, US, EU15, UK, Italy, France, Germany and the World.
- Tables: One year of the most recently released data that is broken out by month. The data are indexed, allowing for transnational analysis. Country coverage includes the US, Japan, Germany, France, Italy and the UK.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.